This article presents the revised consensus criteria for the diagnosis of frontotemporal
dysfunction in amyotrophic lateral sclerosis (ALS) based on an international research …

Background Amyotrophic lateral sclerosis (ALS) people have a high risk of severe mental
disorders, like depression, which impacts their function, quality of life, and mobility. However …

In addition to motor neurone degeneration, up to 50% of amyotrophic lateral sclerosis (ALS)
patients present with cognitive decline. Understanding the neurobiological changes …

Background and purpose This study was undertaken to determine the diagnostic and
prognostic value of a panel of serum biomarkers and to correlate their concentrations with …

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with a rapid course,
characterized by motor neuron dysfunction, leading to progressive disability and death. This …

Background Amyotrophic lateral sclerosis (ALS) is increasingly recognised as a multi-
system disorder, presenting with common and impactful non-motor symptoms, such as …

Aims Intravenous iron therapy can improve symptoms in patients with heart failure, anaemia
and iron deficiency. The mechanisms underlying such an improvement might involve …

Background: A cognitive impairment, ranging from frontotemporal dementia (FTD) to milder
forms of dysexecutive or behavioral dysfunction, is detected in 30–50% of patients affected …

Abstract Background Cognitive screening tests (CSTs) are crucial to neuropsychological
diagnostics, and thus need to be featured by robust psychometric and diagnostic properties …

Abstract Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease leading to
progressive and irreversible muscle atrophy. The diagnosis of ALS is time-consuming and …